OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

OCRF Research Provides Further Evidence that Ovarian Cancer Originates in Fallopian Tube

02/16/2012

 

Work funded by Ovarian Cancer Research Fund has shown that the high-grade serous ovarian cancer arises in the fallopian tube of mice that lack two specific genes. The report appeared online this week in the journal Proceedings of the National Academy of Sciences.

Little is known about how ovarian cancer starts and spreads. Recent research has suggested that the fallopian tube is the site of origin for high-grade serous ovarian cancer, the most deadly subtype of the disease. Researchers at Baylor College of Medicine, including OCRF grantees Martin Matzuk and Shannon Hawkins, deleted two genes, Dicer and Pten, from mice. In these mice, tumors arose from the fallopian tube, spread to the ovary and metastasized throughout the abdomen. Mice that had their ovaries removed still developed cancer, but mice without fallopian tubes did not;  this confirms that the fallopian tube was in fact the origin of the cancer.

The authors of the study hope that this research can shed new light on the origins and progression of this disease. Martin Matzuk, PhD, who is senior author of the study, commented that he hopes the mouse model “will help us translate this information into direct patient care, changing the way we screen, diagnose, and treat this deadliest form of ‘ovarian’ cancer.”

For more information:

Baylor College of Medicine Press Release

Article Abstract